XCaliber Health
Automates healthcare administrative tasks using AI to streamline workflows, reduce burden, and improve operational efficiency.
Overview
XCaliber Health builds AI-driven tools to automate healthcare administrative tasks and workflows for healthcare organizations seeking to reduce overhead and improve operations. The company focuses on non-clinical automation rather than diagnostic or clinical decision tools. Positioned as an operational AI vendor, XCaliber emphasizes administrative automation within healthcare systems as its differentiator. The company raised a $7M seed round on 2026-05-05, with ManchesterStory leading a $6.5M portion; total disclosed funding is $7M.
Funding History
ManchesterStory leads $6.5M round in XCaliber Health to automate healthcare administration
Frequently Asked Questions
- How much funding does AI Funding track for XCaliber Health?
- AI Funding tracks $7M for XCaliber Health across 1 funding round in this database.
- Who are XCaliber Health's investors?
- XCaliber Health's investors include ManchesterStory, Benhamou Global Ventures, Arka Venture Labs.
- What does XCaliber Health do?
- XCaliber Health builds AI-driven tools to automate healthcare administrative tasks and workflows for healthcare organizations seeking to reduce overhead and improve operations. The company focuses on non-clinical automation rather than diagnostic or clinical decision tools. Positioned as an operational AI vendor, XCaliber emphasizes administrative automation within healthcare systems as its differentiator. The company raised a $7M seed round on 2026-05-05, with ManchesterStory leading a $6.5M portion; total disclosed funding is $7M.
- Where is XCaliber Health headquartered?
- XCaliber Health is headquartered in San Francisco, CA.
Investors
Related Insights
A data-driven analysis of AI funding across all 17 sectors — from Foundation Models to AI Healthcare — with sector totals, deal counts, top companies, and investment trends for 2026.
A comprehensive, data-driven analysis of AI venture funding in Q1 2026. $25.9 billion raised across 94 deals, with 14 mega-rounds capturing 79.8% of total capital. Europe breaks out with $6.65B, and billion-dollar seed rounds arrive for the first time.
A deep comparison of Science Corp.'s neurotech-driven brain-computer interfaces and Nscale's AI cloud infrastructure, examining how $230M and $2B in recent funding fuel fundamentally different visions of artificial intelligence.